update on phase i study of plamotamab in r/r nhl
Published 1 year ago • 81 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
1:24
phase i study of plamotamab in r/r nhl
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
2:18
update on phase i/ii study of glofitamab monotherapy in r/r mcl
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
58:27
laboratory nonconformance (event) management
-
4:23
newer treatment options in pv and how the therapeutic landscape is evolving
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
1:07
final results of a phase ii study of add-on parsaclisib for pts with mf and suboptimal rux response
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
3:07
update on the lighthouse (op-108) trial
-
2:09
heart transplantation in attr amyloidosis
-
2:03
an update on the phase ii/iii imerge trial of imetelstat in lr-mds
-
1:44
updates from the phase ii animate trial of nivolumab in r/r chl
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
1:03
late effect surveillance following allosct: the publication of new guidelines
-
1:18
results of a phase i study of sonrotoclax for the treatment of r/r waldenström’s macroglobulinemia
-
2:25
a final update of enhance: reflecting on the negative read-out of the study